Tao Yu
- Cancer Research top 5%
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 6
- Rehabilitation top 2%
- Developmental Neuroscience top 5%
- Oncology top 5%
- Bone health and treatments 6
- Cancer-related Molecular Pathways 5
- Biomaterials top 5%
-
- Bone Metabolism and Diseases 13
- RNA Interference and Gene Delivery 6
- Advanced biosensing and bioanalysis techniques 5
- RNA modifications and cancer 5
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Advanced Materials (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Tao Yu
107 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 546
- Rehabilitation 218
- Developmental Neuroscience 92
- Oncology 587
- Biomaterials 266
Countries citing papers authored by Tao Yu
This map shows the geographic impact of Tao Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Yu more than expected).
Fields of papers citing papers by Tao Yu
This network shows the impact of papers produced by Tao Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Yu. The network helps show where Tao Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tao Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 2 | |
| 8 | A Whole‐Course‐Repair System Based on Neurogenesis‐Angiogenesis Crosstalk and Macrophage Reprogramming Promotes Diabetic Wound Healingbreakdown → | 2023 | 263 |
| 9 | 2022 | 12 | |
| 10 | 2021 | 40 | |
| 11 | 2019 | 21 | |
| 12 | 2019 | 1 | |
| 13 | 2018 | 60 | |
| 14 | 2014 | 35 | |
| 15 | 2012 | 18 | |
| 16 | Professional literature annotation method based on domain ontology | 2011 | 1 |
| 17 | 2009 | 174 | |
| 18 | 2009 | 110 | |
| 19 | 2006 | 8 | |
| 20 | Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status. | 2003 | 167 |
About Tao Yu
Tao Yu is a scholar working on Developmental Neuroscience, Cancer Research and Oncology, having authored 114 papers that have together received 3.0k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (13 papers), MicroRNA in disease regulation (8 papers), RNA Interference and Gene Delivery (6 papers), Bone health and treatments (6 papers), Cancer-related molecular mechanisms research (6 papers), Cancer-related Molecular Pathways (5 papers), Advanced biosensing and bioanalysis techniques (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Cancer Research (546 citations), Rehabilitation (218 citations) and Developmental Neuroscience (92 citations). Tao Yu has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Yuan Xiong, Matthew J. Ellis, Ze Lin, Bobin Mi, Yiqiang Hu, Lang Chen, Guohui Liu, Jane Y. Wu, Takashi Nagasawa and Yan Zhu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.